$5.05
0.79% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US9216591084
Symbol
VNDA
Sector
Industry

Vanda Pharmaceuticals Inc. Target price 2024 - Analyst rating & recommendation

Vanda Pharmaceuticals Inc. Classifications & Recommendation:

Buy
67%
Hold
33%

Vanda Pharmaceuticals Inc. Price Target

Target Price $12.17
Price $5.05
Potential
Number of Estimates 3
3 Analysts have issued a price target Vanda Pharmaceuticals Inc. 2025 . The average Vanda Pharmaceuticals Inc. target price is $12.17. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 2 Analysts recommend Vanda Pharmaceuticals Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Vanda Pharmaceuticals Inc. stock has an average upside potential 2025 of . Most analysts recommend the Vanda Pharmaceuticals Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 192.64 199.45
24.27% 3.53%
Net Margin 1.21% -9.26%
51.98% 864.81%

3 Analysts have issued a sales forecast Vanda Pharmaceuticals Inc. 2024 . The average Vanda Pharmaceuticals Inc. sales estimate is

$199m
Unlock
. This is
4.50% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$205m 7.48%
Unlock
, the lowest is
$195m 1.96%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $193m 24.27%
2024
$199m 3.53%
Unlock
2025
$285m 42.85%
Unlock
2026
$281m 1.23%
Unlock

3 Vanda Pharmaceuticals Inc. Analysts have issued a net profit forecast 2024. The average Vanda Pharmaceuticals Inc. net profit estimate is

$-18.5m
Unlock
. This is
13.07% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-11.7m 28.58%
Unlock
, the lowest is
$-22.2m 35.73%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $2.3m 63.64%
2024
$-18.5m 891.46%
Unlock
2025
$9.3m 150.54%
Unlock
2026
$0.0 100.00%
Unlock

Net Margin

2023 1.21% 51.98%
2024
-9.26% 864.81%
Unlock
2025
3.27% 135.31%
Unlock
2026
0.00% 100.00%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 0.04 -0.32
63.64% 900.00%
P/E negative
EV/Sales negative

3 Analysts have issued a Vanda Pharmaceuticals Inc. forecast for earnings per share. The average Vanda Pharmaceuticals Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.32
Unlock
. This is
14.29% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.20 28.57%
Unlock
, the lowest is
$-0.38 35.71%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $0.04 63.64%
2024
$-0.32 900.00%
Unlock
2025
$0.16 150.00%
Unlock
2026
$0.00 100.00%
Unlock

P/E ratio

Current -17.88 203.17%
2024
-15.95 10.79%
Unlock
2025
31.56 297.87%
Unlock

Based on analysts' sales estimates for 2024, the Vanda Pharmaceuticals Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

-0.37
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -0.39 70.00%
2024
-0.37 5.05%
Unlock
2025
-0.26 30.00%
Unlock
2026
-0.26 1.27%
Unlock

P/S ratio

Current 1.54 59.58%
2024
1.48 4.30%
Unlock
2025
1.03 30.00%
Unlock
2026
1.05 1.25%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today